:: CLDF ::

Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma

Dig Liver Dis. 2022 Sep;54(9):1215-1221. doi: 10.1016/j.dld.2022.03.002. Epub 2022 Mar 27.

Edoardo G Giannini¹, Giulia Pieri², Sara Labanca², Maria Corina Plaz Torres², Antonio Gasbarrini³, Elisabetta Biasini⁴, Claudia Campani⁵, Nora Cazzagon⁶, Francesco Giuseppe Foschi⁷, Andrea Mega⁸, Alberto Masotto⁹, Giovanni Raimondo¹⁰, Gian Ludovico Rapaccini¹¹, Rodolfo Sacco¹², Eugenio Caturelli¹³, Maria Guarino¹⁴, Francesco Tovoli¹⁵, Gianpaolo Vidili¹⁶, Maurizia Rossana Brunetto¹⁷, Gerardo Nardone¹⁸, Gianluca Svegliati-Baroni¹⁹, Donatella Magalotti²⁰, Francesco Azzaroli²¹, Giuseppe Cabibbo²², Maria Di Marco²³, Angelo Sangiovanni²⁴, Franco Trevisani²⁵, Italian Liver Cancer (ITA.LI.CA) Study Group

Longitudinal Assessment of Bile Duct Loss in Primary Biliary Cholangitis

Am J Gastroenterol. 2022 Sep 1. doi: 10.14309/ajg.0000000000001985. Online ahead of print.

Julian Hercun¹, Mazen Noureddin¹, Nabil Noureddin¹, Jason Eccleston¹, Daniel Woolridge¹, T Jake Liang¹, Michele Tana¹, David E Kleiner², Gracia Viana Rodriguez¹, Christopher Koh¹, Jay H Hoofnagle¹, Theo Heller¹

Update on the Pharmacological Treatment of Primary Biliary Cholangitis

Biomedicines. 2022 Aug 20;10(8):2033. doi: 10.3390/biomedicines10082033.

Annarosa Floreani¹², Daniela Gabbia³, Sara De Martin³

Challenges and opportunities in achieving effective regulatory T cell therapy in autoimmune liver disease

Semin Immunopathol. 2022 Jul;44(4):461-474. doi: 10.1007/s00281-022-00940-w.Epub 2022 May 31.

N Richardson¹², G E Wootton³⁴, A G Bozward³⁴, Y H Oo⁵⁶⁷⁸

Do Patients with Autoimmune Conditions Have Less Access to Liver Transplantation despite Superior Outcomes?

J Pers Med. 2022 Jul 17;12(7):1159. doi: 10.3390/jpm12071159.

Stephanie S Keeling¹, Malcolm F McDonald², Adrish Anand¹, Cameron R Goff¹, Caroline R Christmann¹, Spencer C Barrett¹, Michael Kueht³, John A Goss⁴, George Cholankeril⁴, Abbas Rana⁴

Individual dynamic prediction of clinical endpoint from large dimensional longitudinal biomarker history: a landmark approach

BMC Med Res Methodol. 2022 Jul 11;22(1):188. doi: 10.1186/s12874-022-01660-3.

Anthony Devaux¹, Robin Genuer²³, Karine Peres², Cécile Proust-Lima²

Waitlist mortality in patients with autoimmune liver diseases

Ann Hepatol. 2022 Jul 11;100742. doi: 10.1016/j.aohep.2022.100742. Online ahead of print.

Daniela Goyes¹, Romelia Barba², Esli Medina-Morales², Behnam Saberi², Vilas Patwardhan², Alan Bonder³

Waitlist mortality in patients with autoimmune liver diseases

Ann Hepatol. 2022 Jul 11;100742. doi: 10.1016/j.aohep.2022.100742. Online ahead of print.

Daniela Goyes¹, Romelia Barba², Esli Medina-Morales², Behnam Saberi², Vilas Patwardhan², Alan Bonder³

How genetic risk contributes to autoimmune liver disease

Semin Immunopathol. 2022 Jul;44(4):397-410. doi: 10.1007/s00281-022-00950-8.Epub 2022 Jun 1.

David Ellinghaus¹

10.

Network Proximity-Based Drug Repurposing Strategy for Early and Late Stages of Primary Biliary Cholangitis

Biomedicines. 2022 Jul 13;10(7):1694. doi: 10.3390/biomedicines10071694.

Endrit Shahini¹, Giuseppe Pasculli², Andrea Mastropietro², Paola Stolfi³, Paolo Tieri³, Davide Vergni³, Raffaele Cozzolongo¹, Francesco Pesce⁴, Gianluigi Giannelli¹

11.

Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis

J Hepatol. 2022 Jun 28;S0168-8278(22)00411-1. doi: 10.1016/j.jhep.2022.06.017.Online ahead of print.

Christophe Corpechot¹, Fabrice Carrat², Farid Gaouar³, Frederic Chau², Gideon Hirschfield⁴, Aliya Gulamhusein⁴, Aldo J Montano-Loza⁵, Ellina Lytvyak⁵, Christoph Schramm⁶, Albert Pares⁷, Ignasi Olivas⁷, John E Eaton⁸, Karim T Osman⁸, George Dalekos⁹, Nikolaos Gatselis⁹, Frederik Nevens¹⁰, Nora Cazzagon¹¹, Alessandra Zago¹¹, Francesco Paolo Russo¹¹, Nadir Abbas¹², Palak Trivedi¹², Douglas Thorburn¹³, Francesca Saffioti¹³, Laszlo Barkai¹³, Davide Roccarina¹³, Vicenza Calvaruso¹⁴, Anna Fichera¹⁴, Adele Delamarre¹⁵, Esli Medina-Morales¹⁶, Alan Bonder¹⁶, Vilas Patwardhan¹⁶, Cristina Rigamonti¹⁷, Marco Carbone¹⁸, Pietro Invernizzi¹⁸, Laura Cristoferi¹⁸, Adriaan van der Meer¹⁹, Rozanne de Veer¹⁹, Ehud Zigmond²⁰, Eyal Yehezkel²⁰, Andreas E Kremer²¹, Ansgar Deibel²¹, Jerome Dumortier²², Tony Bruns²³, Karsten Große²³, Georges-Philippe Pageaux²⁴, Aaron Wetten²⁵, Jessica Dyson²⁵, David Jones²⁵, Olivier Chazouilleres³, Bettina Hansen⁴, Victor de Lédinghen¹⁵, Global & ERN Rare-Liver PBC Study Groups

12.

Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis

Dig Dis Sci. 2022 Jun 15. doi: 10.1007/s10620-022-07581-x. Online ahead of print.

Marlyn J Mayo¹, Elizabeth Carey², Helen T Smith³, Andrea R Mospan⁴, Megan McLaughlin⁵, April Thompson⁶, Heather L Morris⁴, Robert Sandefur⁴, W Ray Kim⁷, Christopher Bowlus⁸, TARGET-PBC Investigators; Cynthia Levy⁹

13.

Clinical Patterns of Primary Biliary Cholangitis: Comparison between Two European case series

Rev Recent Clin Trials. 2022 Jun 17. doi: 10.2174/1574887117666220617095856.Online ahead of print.

Ludovico Abenavoli¹, Anna Caterina Procopio¹, Pietro Cinaglia¹, Christian Zanza², Claudio Delle Grazie³, Yaroslava Longhitano², Pavla Libicherova⁴, Francesco Luzza¹

14.

The National Audit of Primary Biliary Cholangitis (PBC) in the United Kingdom: Defining the Audit Dataset and Data Collection System

Cureus. 2022 Jun 2;14(6):e25609. doi: 10.7759/cureus.25609. eCollection 2022 Jun.

Laura Burke¹, Steve Flack², Rebecca Jones³, Richard J Aspinall⁴, Douglas Thorburn⁵, David E Jones⁶, Conor Braniff⁷, Collette Thain⁸, Andrew Yeoman⁹, Joanna A Leithead¹⁰, Palak J Trivedi¹¹, George Mells², Laith Alrubaiy¹²

15.

Setting Up a Local Registry to Improve the Care of Patients With Primary Biliary Cholangitis

Cureus. 2022 May 23;14(5):e25247. doi: 10.7759/cureus.25247. eCollection 2022 May.

Laith Alrubaiy¹, Ceyhun A Oztumer²

16.

Portal pressure is of significant prognostic value in primary biliary cholangitis

Liver Int. 2022 May 27. doi: 10.1111/liv.15289. Online ahead of print.

Thomas W Warnes¹, Stephen A Roberts², Alexander Smith¹, Victor M Cope³, Patricia Vales⁴, Raymond McMahon⁵

17.

The relationship between disease activity and UDCA response criteria in primary biliary cholangitis: A cohort study

EBioMedicine. 2022 May 21;80:104068. doi: 10.1016/j.ebiom.2022.104068. Online ahead of print.

David E J Jones¹, Aaron Wetten², Ben Barron-Millar³, Laura Ogle³, George Mells⁴, Steven Flack⁴, Richard Sandford⁴, John Kirby³, Jeremy Palmer³, Sophie Brotherston³, Laura Jopson³, John Brain³, Graham R Smith⁵, Steve Rushton⁶, Rebecca Jones⁷, Simon Rushbrook⁸, Douglas Thorburn⁹, Stephen D Ryder¹⁰, Gideon Hirschfield¹¹, UK-PBC Research Consortium; Jessica K Dyson²

18.

High-Resolution Exposomics and Metabolomics Reveals Specific Associations in Cholestatic Liver Diseases

Hepatol Commun. 2022 May;6(5):965-979. doi: 10.1002/hep4.1871. Epub 2021 Nov 26.

Douglas I Walker^#¹, Brian D Juran^#², Angela C Cheung³, Erik M Schlicht², Yongliang Liang⁴, Megan Niedzwiecki¹, Nicholas F LaRusso², Gregory J Gores², Dean P Jones⁴, Gary W Miller⁵, Konstantinos N Lazaridis²

19.

The Role of Epigenetics in Primary Biliary Cholangitis

Int J Mol Sci. 2022 Apr 28;23(9):4873. doi: 10.3390/ijms23094873.

Alessio Gerussi¹², Elvezia Maria Paraboschi³⁴, Claudio Cappadona³⁴, Chiara Caime¹², Eleonora Binatti¹², Laura Cristoferi¹², Rosanna Asselta³⁴, Pietro Invernizzi¹²

20.

Rates of decompensation, hepatocellular carcinoma and mortality in AMA-negative primary biliary cholangitis cirrhosis

Liver Int. 2022 Feb;42(2):384-393. doi: 10.1111/liv.15079. Epub 2021 Oct 12.

Binu V John¹², Bassam Dahman³, Yangyang Deng³, Nidah S Khakoo⁴, Tamar H Taddei⁵⁶, David E Kaplan⁷⁸, Cynthia Levy²

21.

Protein and miRNA profile of circulating extracellular vesicles in patients with primary sclerosing cholangitis

Sci Rep. 2022 Feb 22;12(1):3027. doi: 10.1038/s41598-022-06809-0.

Davide Povero^#¹, Masahiko Tameda^#², Akiko Eguchi², Wenhua Ren³, Jihoon Kim⁴, Robert Myers⁵, Zachary D Goodman⁶, Stephen A Harrison⁷, Arun J Sanyal⁸, Jaime Bosch⁹¹⁰, Lucila Ohno-Machado⁴, Ariel E Feldstein¹¹

22.

Primary biliary cholangitis in pregnancy: A systematic review with meta-analysis

Hepatobiliary Pancreat Dis Int. 2022 Mar 10;S1499-3872(22)00023-6.doi: 10.1016/j.hbpd.2022.03.005. Online ahead of print.

Hydar El Jamaly¹, Guy D Eslick², Martin Weltman³

23.

Primary biliary cholangitis: advances in understanding and management

Br J Hosp Med (Lond). 2022 Mar 2;83(3):1-9. doi: 10.12968/hmed.2021.0450.Epub 2022 Mar 24.

Alex Smith¹, Benjamin Giles¹, Richard J Aspinall¹

24.

A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis

J Hepatol. 2022 Mar 30;S0168-8278(22)00187-8. doi: 10.1016/j.jhep.2022.02.033.Online ahead of print.

Christopher L Bowlus¹, Michael R Galambos², Richard J Aspinall³, Gideon M Hirschfield⁴, David E J Jones⁵, Yvonne Dörffel⁶, Stuart C Gordon⁷, Stephen A Harrison⁸, Andreas E Kremer⁹, Marlyn J Mayo¹⁰, Paul J Thuluvath¹¹, Cynthia Levy¹², Mark G Swain¹³, Guy W Neff¹⁴, David A Sheridan¹⁵, Carmen M Stanca¹⁶, Christoph P Berg¹⁷, Aparna Goel¹⁸, Mitchell L Shiffman¹⁹, John M Vierling²⁰, Pol Boudes²¹, Alexandra Steinberg²¹, Yun-Jung Choi²¹, Charles A McWherter²¹

25.

Mechanisms and molecules: What are the treatment targets for primary biliary cholangitis?

Hepatology. 2022 Feb 13. doi: 10.1002/hep.32405. Online ahead of print.

Marlyn J Mayo¹

Subscribe